Versartis (United States)

Recent papers from Versartis (United States)

1. C33-18 Real-World Clinical Burden of Severe Asthma With Comorbid COPD: Findings From the INSIGHTS Pragmatic RegistryAmerican Journal of Respiratory and Critical Care Medicine · 2026
2. Integrated Process Modeling—A Process Validation Life Cycle CompanionBioengineering · 2017
3. A Randomized Safety and Efficacy Study of Somavaratan (VRS-317), a Long-Acting rhGH, in Pediatric Growth Hormone DeficiencyThe Journal of Clinical Endocrinology & Metabolism · 2015
4. A Long-Acting Human Growth Hormone With Delayed Clearance (VRS-317): Results of a Double-Blind, Placebo-Controlled, Single Ascending Dose Study in Growth Hormone–Deficient AdultsThe Journal of Clinical Endocrinology & Metabolism · 2013
5. A Novel Long-Acting Human Growth Hormone Fusion Protein (VRS-317): Enhanced In Vivo Potency and Half-LifeJournal of Pharmaceutical Sciences · 2012
6. Gcg-XTEN: An Improved Glucagon Capable of Preventing Hypoglycemia without Increasing Baseline Blood GlucosePLoS ONE · 2010